Home  »  Company  »  Glenmark Pharmaceuticals Ltd.  »  Quotes  »  Audited Results
Enter the first few characters of Company and click 'Go'

Audited Results of Glenmark Pharmaceuticals Ltd. Company

(Rs in Cr.) Mar 31, 2016 Mar 31, 2015 Mar 31, 2014 Mar 31, 2013 Mar 31, 2012
Operating Income 6,113.50 5,085.60 2,300.90 1,949.30 1,619.98
Manufacturing Expenses 95.56 88.42 14.19 11.26 62.79
Personnel Expenses 771.63 662.25 395.35 303.02 246.81
Selling Expenses 0 0 0 0 284.35
Administrative Expenses 1,494.89 1,152.78 772.77 749.42 231.94
Expenses Capitalised 0 0 0 0 0
Cost Of Sales 4,357.85 3,620.61 1,804.94 1,616.86 1,255.65
Operating Profit 1,755.65 1,464.99 495.97 332.44 364.33
Other Recurring Income 117.28 84.94 67.13 116.25 55.10
Adjusted PBDIT 1,872.93 1,549.93 563.10 448.69 419.44
Financial Expenses 36.22 30.19 30.98 43.69 60.87
Depreciation 112.10 119.46 30.20 25.04 21.11
Other Write offs 0 0 0 0 0
Adjusted PBT 1,724.61 1,400.28 501.92 379.95 337.46
Tax Charges 256.18 224.02 68.10 -6.15 18.80
Adjusted PAT 1,468.43 1,176.26 433.82 386.11 318.66
Non Recurring Items 0 -168.74 0 0 -53.36
Other Non Cash adjustments 0 0 0 0 0
Reported Net Profit 1,468.43 1,007.52 433.82 386.11 265.30
Equity Dividend 47.25 42.91 45.01 44.95 45.33
Preference Dividend 0 0 0 0 0
Retained Earnings 5,425.41 4,027.07 1,877.21 1,537.23 1,240.60

Find IFSC